Anxiety Disorders & Nursing Practice – Comprehensive Study Notes

Anxiety: Functional vs. Pathological

  • Anxiety as an Adaptive Signal
    • Heightens awareness, keeps clinicians “on their toes.”
    • Mild, situational anxiety before clinical practice or public speaking is normal and beneficial.
  • Red-Flag Transition to Maladaptive Anxiety
    • Performance becomes impaired (paralysis, freezing, clouded thinking).
    • Out-of-proportion response to the trigger.
    • Interference with social, occupational, or other key areas of functioning → pathological.
  • Behavioral Guidance for Nurses & Students
    • A little worry about IV dose, medication accuracy, etc., is protective.
    • If routine care consistently produces debilitating fear, consider slower-paced units.

Common Somatic & Psychological Manifestations

  • Cognitive / Affective
    • Excessive fear, rumination, sense of impending doom.
    • Difficulty making decisions, irritability.
  • Autonomic / Somatic
    • Heart palpitations, chest tightness.
    • Sweating, tremors, chills.
    • GI upset: nausea, diarrhea; urinary urgency (fight-or-flight rebound).
    • Insomnia → chronic fatigue.
    • Note: Patients who verbalize “I’m going to die” = high-priority assessment.

Panic Disorder (PD)

  • Panic Attack – DSM-5 Definition
    • Sudden surge of intense fear/discomfort, peaks in 102010\text{–}20 min.
    • Must include 4\ge 4 of 13 symptoms: pounding heart, chest pain, sweating, tremor, SOB, choking, nausea, dizziness, chills/heat, paresthesias, derealization/depersonalization, fear of losing control, fear of dying.
  • Panic Disorder Criteria
    • 2\ge 2 unexpected (uncued) panic attacks.
    • Persistent worry or maladaptive behavior change (e.g., avoidance) ≥ 1 month.
    • Not due to substances, medical illness, or other mental disorder.
  • Clinical Course
    • Attacks can occur in safe places → unpredictability increases anxiety.
    • Anticipatory anxiety and avoidance (parks, elevators, driving) → functional restriction, may evolve into agoraphobia.
  • Epidemiology & Etiology
    • Female:Male=2:1\text{Female}:\text{Male} = 2:1.
    • Familial/genetic loading; multifactorial neurobiology.
  • Management
    • Cognitive-Behavioral Therapy (CBT) – 5 core steps: education, monitoring diary, breathing/relaxation, cognitive reframing, graded exposure.
    • Medications: SSRIs (first-line), benzodiazepines (short-term), anticonvulsants in severe cases.
    • Goal = prevent avoidance & restore function.

Generalized Anxiety Disorder (GAD)

  • Key Features
    • Excessive, persistent, and unreasonable worry about multiple domains (finances, family, work).
    • Often no specific trigger; “free-floating” anxiety.
  • DSM-5 Diagnostic Thresholds
    • Duration: anxiety present “more days than not” for 6\ge 6 months (≈ 90\ge 90 of 180180 days).
    • Difficulty controlling the worry.
    • Adults: 3\ge 3 associated symptoms; children: 1\ge 1.
    • Causes clinically significant distress/impairment.
    • Not due to substances, medical condition, or another mental disorder.
  • Associated Symptoms
    • Restlessness/edginess, easy fatigue, poor concentration, irritability, muscle tension, sleep disturbance.
  • Epidemiology
    • Lifetime prevalence ≈ 3%3\%.
    • 2:12:1 female predominance.
    • Runs in families; gene–environment interplay.
  • Treatment
    • CBT – long-term superiority over meds for relapse prevention.
    • Pharmacologic options: SSRIs, SNRIs, benzodiazepines (short-term), buspirone.
    • Combined therapy often most effective.
  • Continuum Concept
    • Anxiety exists on a spectrum; many “functional worriers” never meet full DSM criteria.
    • Personal anecdote: effective SSRI use can markedly improve quality of life; meds need not be lifelong.

Social Anxiety Disorder (Social Phobia)

  • Core Fear
    • Being negatively evaluated, embarrassed, or humiliated in social or performance situations.
  • DSM-5 Points
    • Persistent (≥ 66 months).
    • Causes significant distress/impairment.
    • Not attributable to substances/medical or other mental disorder.
  • Subtypes & Presentations
    • Generalized social interactions (e.g., meeting new people, small talk).
    • Performance-only (public speaking, toasts).
    • Ego-dystonic: sufferers know fear is irrational, which may worsen anxiety.
  • Physiological & Behavioral Expressions
    • Blushing, trembling, sweating → worsen fear of scrutiny.
    • Severe cases: derealization, reliance on alcohol (“liquid courage”) → addiction risk.
  • Differential Highlights
    • Versus GAD: social judgment focus vs. broad worry.
    • Versus agoraphobia: fear of entrapment/escape, not judgment.
    • Versus PD: spontaneous uncued attacks vs. situation-bound fear of scrutiny.
  • Management
    • CBT (social-skills training, exposure, cognitive restructuring).
    • Pharmacology: SSRIs, SNRIs, benzodiazepines, beta blockers for performance anxiety.
    • Long-term: psychotherapy preferred to avoid medication side effects.

Physiological Underpinnings & Etiological Themes

  • Multifactorial model:
    • Genetic susceptibility.
    • Neurochemical differences (serotonin, norepinephrine, GABA).
    • Environmental precipitants (stress, trauma, neglect).
    • Psychodynamic theories (id/ego/superego conflicts) acknowledged but less emphasized clinically.

Nursing Implications & Practical Takeaways

  • Assessment
    • Screen for severity, functional impact, substance use, suicidal ideation.
    • Recognize red-flag somatic complaints (chest pain, “sense of doom”).
  • Intervention Hierarchy
    • Safety → grounding techniques → engage resources (colleagues, rapid response).
    • Provide patient education on anxiety continuum and treatment options.
  • Self-Care for Nurses
    • Normalization of mild anticipatory anxiety.
    • Seek CBT or pharmacologic support if worry becomes persistent or sleep-impairing.
    • Avoid reliance on maladaptive coping (e.g., alcohol).

Key Numbers & Formula-Style Facts

  • Panic Disorder: Female:Male=2:1\text{Panic Disorder: Female}:\text{Male} = 2:1.
  • GAD prevalence3%\text{GAD prevalence} \approx 3\%.
  • Duration cutoffs:
    • PD behavior change ≥ 11 month after attack(s).
    • GAD worry ≥ 66 months.
    • Social Anxiety ≥ 66 months.
  • GAD frequency guide: 90\ge 90 of 180180 days exhibit excessive worry.

Mnemonic Corner

  • Panic Attack – “STUDENTS Fear The 13 Cs”
    • Sweating, Trembling, Unsteadiness (dizzy), Derealization, Excessive heart rate, Nausea, Tingling (paresthesia), Shortness of breath
    • Fear of dying/losing control, Chills/heat, Chest pain, Choking.

Ethical & Practical Reflections

  • Stigma reduction: normalize discussion of medications & therapy.
  • Avoid unit assignment mismatching; ensure safe practice environments for nurses prone to high anxiety.
  • Promote CBT literacy among healthcare teams; it recurs across behavioral-health curricula.